Periodic paralysis: An unusual presentation of drug‑induced hyperkalemia

ABSTRACT

Hyperkalemia is a life-threatening electrolyte abnormality. The most common cause of hyperkalemia includes renal disease and ingestion of medications. Drug-induced hyperkalemia may develop in patients with underlying renal impairment, disturbed cellular uptake of potassium load, excessive ingestion or infusion of potassium-containing substances. We report a case of "drug-induced severe hyperkalemia" presenting as periodic paralysis. A 67-year-old diabetic and hypertensive woman presented to emergency department with the complaint of intermittent episode of inability to walk for the past 5 days. Each episode lasted for 15-20 minutes and was associated with breathlessness and restlessness. There was no family history of periodic paralysis and drug history revealed that the patient was onolmesartan 20 mg per day (for past 2 years), perindopril 4 mg per day (for past 16 months), and torsemide 10 mg/day. On examination patient was found to be conscious, alert, and afebrile. Vitals were normal. Examination of cardiovascular and respiratory system did not reveal any significant finding. Blood report of the patient showed serum K+ level 8.6 mmol/l. All other investigations were within normal limits. A diagnosis of drug-induced hyperkalemia was made. Patient responded well to the symptomatic treatment. To the best of the author’s knowledge, this is the first case report of drug-induced hyperkalemia presenting as periodic paralysis.

KEYWORDS

• Drug-induced
• electrolyte abnormality
• hyperkalemia
• periodic paralysis

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/0976-500X.124429Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 5, ISSUE 1Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case seriesMaulin Mehta, Jay Shah, Tejas Khakhkhar, Rima Shah, K. G. Hemavathi · pp. 59–60Case ReportSame type: Article
• Article · VOLUME 5, ISSUE 1Cholestatic presentation of yellow phosphorus poisoningC. P. Lakshmi, Amit Goel, Debdatta Basu · pp. 67–69Case ReportSame type: Article
• Article · VOLUME 5, ISSUE 1Antibiotics with a curse of cardiovascular riskG Sivagnanam · pp. 71–72Same type: Article
• Article · VOLUME 5, ISSUE 1The new factor Xa inhibitor: ApixabanSangeeta Bhanwra, Kaza Ahluwalia · pp. 12–14Same type: Article